Αρχική World News Multicancer early detection test detects tumour-derived cfDNA and demonstrates robust performance characteristics... World News Multicancer early detection test detects tumour-derived cfDNA and demonstrates robust performance characteristics with a favourable safety profile Από Ogkologos - 6 Οκτωβρίου, 2026 103 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from the PATHFINDER 2 study Source ΠΑΡΟΜΟΙΑ ΑΡΘΡΑΠΕΡΙΣΣΟΤΕΡΑ ΑΠΟ ΤΟΝ ΔΗΜΙΟΥΡΓΟ Ahead of the Special European Council Meeting on 26-27 November, ESMO Calls on EU Governments to Continue Support for the Cancer Mission European Parliament backs key priorities advocated by ESMO for cancer research and innovation FDA approves giredestrant in combination with everolimus for ER-positive, HER2-negative, ESR1-mutated locally advanced or metastatic breast cancer MOST POPULAR Atezolizumab Approved for Initial Treatment of Metastatic Lung Cancer 7 Ιανουαρίου, 2019 Immunotherapy approved for some people with oesophageal cancer on NHS in... 20 Οκτωβρίου, 2021 Professional Runner and Mom of Two Shares Photo Of Belly Cavity... 17 Σεπτεμβρίου, 2019 Catch-Up HPV Testing May Help Prevent Cervical Cancer in Some Over... 1 Σεπτεμβρίου, 2023 Φόρτωση περισσοτέρων HOT NEWS Study Advances Fertility Preservation Approach for Male Cancer Survivors Treatment Guided by Comprehensive Genomic Profiling and Expert MTB Decision-Making Improves... Child Cancer Patient And His Dad Have A Little Fun When... Can Cancer Symptoms Be Mistaken for Menopause?